March 25, 2019
Rose
The disease is too complex, experts argue. But drugmakers are still hoping for a foot in that lucrative door. In other pharmaceutical news: insulin drug pricing, pharmacy benefits managers, postpartum depression drugs, a rare genetic disease, and more.
from Kaiser Health News https://ift.tt/2TrTYrD
March 25, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Pancreatic Cancer Is So Lethal Because Patients Rarely Have Symptoms In Early Stages Of Disease- A Look At How David Koch Contributed To The Health Care Landscape
- Beyond Medicaid And Food Stamps: ‘Public Charge’ Immigration Rule Could Have Wide-Reaching Public Health Effects
- Judge Expected To Rule Today In Oklahoma Opioid Case Over What Role Drugmakers Played In Epidemic
- Yes, Red Flag Laws Can Work To Curb Gun Violence. But Infrastructure That They Require Is Often Lacking, Experts Say.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment